Stockreport

Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company dev [Read more]